CNXC vs INCY · rev $4.96B vs P/E 14, rev $5.14B
Concentrix Corporation (CNXC) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Concentrix Corporation (CNXC) is a information technology services company listed on US.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported CNXC revenue for 2026-05-31 was $4.96B. Net income was $76.9M. Revenue was up 98.5% from 2026-02-28 to 2026-05-31. CNXC currently screens at market cap $1.70B.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
CNXC currently screens at market cap $1.70B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the CNXC and INCY stock pages for the full models.
Not investment advice.